ArticleEndocrinology and metabolism (Seoul, Korea)2024

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

Nam Hoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.